According to Mersana Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.04. In 2022 the company made an earnings per share (EPS) of -$2.19 an increase over its 2021 EPS that were of -$2.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.04 | -6.85% |
2022 | -$2.19 | -8.75% |
2021 | -$2.40 | 66.67% |
2020 | -$1.44 | 336.36% |
2019 | -$0.33 | -88.17% |
2018 | -$2.79 | -63.53% |
2017 | -$7.65 | 876.74% |
2016 | -$0.78 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 6.86% | ๐บ๐ธ USA |